River Vest Venture Management LLC Allakos Inc. Transaction History

River Vest Venture Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$2.13 - $5.55 $212,126 - $552,724	99,590 Added 2.04%	4,987,522 $11.3 Billion
Q1 2021 Aug 11, 2021	SELL	$109.73 - $153.66 $94.7 Million - $133 Million	-862,574 Reduced 15.0%	4,887,932 $561 Million
Q4 2020 Aug 11, 2021	BUY	$79.58 - $152.45 $458 Million - $877 Million	5,750,506 New	5,750,506 $805 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of River Vest Venture Management LLC, based on Form 13F filings with the SEC.

Stay updated on River Vest Venture Management LLC with notifications on news.